| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 257,100 | 277,300 | 307,300 | 289,500 | | Cost of Revenue | 205,000 | 214,200 | 230,300 | 227,600 | | | Gross Profit | 52,100 | 63,100 | 77,000 | 61,900 | | | Operating Expenses | | Research Development | 8,400 | 6,400 | 7,800 | 7,300 | | Selling General and Administrative | 24,100 | 27,000 | 29,300 | 24,000 | | Non Recurring |
-
|
-
|
-
| 1,300 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 19,600 | 29,700 | 39,900 | 29,300 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
| 16,100 | | Earnings Before Interest And Taxes | 19,600 | 29,700 | 39,900 | 29,300 | | Interest Expense | 6,900 | 7,500 | 5,400 | 4,700 | | Income Before Tax | 12,700 | 22,200 | 34,500 | 24,600 | | Income Tax Expense | 2,500 | 5,700 | 11,200 | (3,200) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 10,400 | 16,800 | 23,400 | 28,300 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 10,400 | 16,800 | 23,400 | 28,300 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $10,400 | $16,800 | $23,400 | $28,300 |
|
0.02% Nasdaq 0.00%
Income Statement
